Cadila manufacturing facility in India gets FDA Form 483 for 5 observations

11th September 2018 Uncategorised 0

Liva Pharmaceuticals, a wholly owned manufacturing facility of Indian drugmaker Cadila Healthcare, was hit with a Form 483 by the FDA following an inspection of its plant in Vadodara, India.

More: Cadila manufacturing facility in India gets FDA Form 483 for 5 observations
Source: fierce